CASI Pharmaceuticals (CASI)

• Market cap: $21M
• 1 day: 0.99%
• 5 days: -15.7%
• 1 month: -35.44%
• 3 months: -58.2%
• 6 months: -45.74%
• Year to date: -65.77%
• 1 year: -73.16%
• 5 years: -95.9%
• 10 years: -90.29%
• Sector: Healthcare
• Industry: Biotechnology

About: CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Employees: 233